Press release
Non-Steroidal Anti-Inflammatory Drugs Market Demand and Opportunities Shaping the Future by 2031 | Reckitt Benckiser Group PLC, and Assertio Holdings, Inc
Non-Steroidal Anti-Inflammatory Drugs Market
The non-steroidal anti-inflammatory drugs market is estimated to be valued at USD 24.4 Bn in 2024 and is expected to reach USD 36 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Non-Steroidal Anti-Inflammatory Drugs market has been growing significantly in recent years, driven by a number of key factors, such as increasing demand for its products, expanding customer base, and technological advancements. This report provides a comprehensive analysis of the Non-Steroidal Anti-Inflammatory Drugs market, including market size, trends, drivers and constraints, competitive aspects, and prospects for future growth.
Request a Sample Copy with More Details: - https://www.coherentmi.com/industry-reports/non-steroidal-anti-inflammatory-drugs-market/request-sample
Scope of the Non-Steroidal Anti-Inflammatory Drugs Market:
The Non-Steroidal Anti-Inflammatory Drugs market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Major Players Operating in the Non-Steroidal Anti-Inflammatory Drugs Market:
• Bayer AG
• Sanofi
• GSK plc
• Heron Therapeutics
• Inc.
• Strides Pharma Science Limited
• Sun Pharmaceutical Industries Ltd.
• Reckitt Benckiser Group PLC
• Assertio Holdings
Non-Steroidal Anti-Inflammatory Drugs Market Segments:
❖ By Indication
• Arthritis
• Migraine
• Ophthalmic Diseases
• Others
❖ By Route of Administration
• Oral
• Parenteral
❖ By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
Geographical Landscape:
The Non-Steroidal Anti-Inflammatory Drugs Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities.
➤ North America (United States, Canada, and Mexico)
➤ Europe (UK, Germany, France, Russia, and Italy)
➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
➤ South America (Brazil, Colombia, Argentina, etc.)
➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)
This report offers actionable growth insights and an extensive study comprising secondary research, primary interviews with industry stakeholders, and competitors, validation, and triangulation with the CoherentMI regional database. Experts have detailed primary records with the market players across the value chain in all regions and industry experts to obtain qualitative and quantitative insights.
Trends and Opportunities:
The Non-Steroidal Anti-Inflammatory Drugs market has seen several trends in recent years, and understanding these trends is crucial to stay ahead of the competition. The increasing demand for Non-Steroidal Anti-Inflammatory Drugs in various industries presents several growth opportunities for players in the market.
Would you like to have an opportunity to explore more explore more details, If yes, access our full report @ https://www.coherentmi.com/industry-reports/non-steroidal-anti-inflammatory-drugs-market
Key Benefits for Stakeholders:
⏩ The study includes a comprehensive analysis of current Non-Steroidal Anti-Inflammatory Drugs Market trends, estimations, and market size dynamics from 2024 to 2031 in order to identify the most potential prospects.
⏩ The five forces study by Porter underlines the role of buyers and suppliers in aiding stakeholders in making profitable business decisions and expanding their supplier-buyer network.
⏩ In-depth research, as well as market size and segmentation, can assist you in identifying current Non-Steroidal Anti-Inflammatory Drugs Market opportunities.
⏩ The largest countries in each area are mapped based on their market revenue contribution.
⏩ The Non-Steroidal Anti-Inflammatory Drugs Market research report provides an in-depth analysis of the top competitors in the market.
Global Non-Steroidal Anti-Inflammatory Drugs Market 2024 Key Insights:
▶ Research and analyze the Non-Steroidal Anti-Inflammatory Drugs Market standing and future forecast associated with production, Market price structure, consumption, and historical knowledge.
▶ The report understands the structure of Non-Steroidal Anti-Inflammatory Drugs Market trade by distinctive its varied segments and sub-segments.
▶ Market report split the breakdown knowledge by company, products, end-user, and prime countries, with market history knowledge from 2017 to 2024 and forecast to 2031.
▶ Analysis of Non-Steroidal Anti-Inflammatory Drugs Market regarding individual growth trends, future prospects, and their contribution to the overall market.
▶ Global Non-Steroidal Anti-Inflammatory Drugs Market 2024 report analyzes competitive expansions like agreements, new product launches, and acquisitions.
▶ This research report targets the global key players to characterize sales volume, market revenue, growth potential, drivers, SWOT analysis, and development plans in coming years.
Get access to the latest Edition of this Market Study (comprising 150 + pages ) @ https://www.coherentmi.com/industry-reports/non-steroidal-anti-inflammatory-drugs-market/buynow
Reasons to buy:
👉 Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
👉 Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
👉 Classify potential new clients or partners in the target demographic.
👉 Develop tactical initiatives by understanding the focus areas of leading companies.
👉 Plan mergers and acquisitions meritoriously by identifying Top Manufacturers.
👉 Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
👉 Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Author Bio:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
Antibody Discovery Market https://www.coherentmi.com/industry-reports/antibody-discovery-market
Angio Suites Market https://www.coherentmi.com/industry-reports/angio-suites-market
Global Kras Inhibitors Market https://www.coherentmi.com/industry-reports/global-kras-inhibitors-market
Lactose Intolerance Market https://www.coherentmi.com/industry-reports/lactose-intolerance-market
☎ Contact Us:
Mr. Shah
CoherentMI,
U.S.: +1-650-918-5898
U.K: +44-020-8133-4027
Australia: +61-2-4786-0457
INDIA: +91-848-285-0837
Email: sales@coherentmi.com
Website: https://www.coherentmi.com
About CoherentMI:
At CoherentMI, we are a leading global market intelligence company dedicated to providing comprehensive insights, analysis, and strategic solutions to empower businesses and organizations worldwide. Moreover, CoherentMI is a subsidiary of Coherent Market Insights Pvt Ltd., which is a market intelligence and consulting organization that helps businesses in critical business decisions. With our cutting-edge technology and experienced team of industry experts, we deliver actionable intelligence that helps our clients make informed decisions and stay ahead in today's rapidly changing business landscape.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Steroidal Anti-Inflammatory Drugs Market Demand and Opportunities Shaping the Future by 2031 | Reckitt Benckiser Group PLC, and Assertio Holdings, Inc here
News-ID: 3697180 • Views: …
More Releases from CoherentMI
Global Pharmaceutical Glass Tubing Market: Demand, Emerging Trends, Revenue, Key …
According to a new report published by CoherentMI Global pharmaceutical glass tubing market is expected to reach US$ 11.2 Bn by 2030, from US$ 8.3 Bn in 2023, exhibiting a CAGR of 7.1% during the forecast period.
Most recent Report, named "Global Pharmaceutical Glass Tubing Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a complete investigation of the business, which includes bits of knowledge available examination.…
Global Feeding Tubes Market Overview, Trends, Insights, Growth, Forecast with a …
According to a new report published by CoherentMI The global feeding tubes market size is expected to reach US$ 9.69 billion by 2030, from US$ 6.34 billion in 2023, growing at a CAGR of 6.2% during the forecast period.
Most recent Report, named "Global Feeding Tubes Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a complete investigation of the business, which includes bits of knowledge available…
United States Pharmaceuticals Market: With CAGR of 8.6% by 2024 - 2031 Market Si …
According to a new report published by CoherentMI The United States Pharmaceuticals Market size is expected to reach US$ 1,068.02 billion by 2030, from US$ 599.47 billion in 2023, at a CAGR of 8.6% during the forecast period.
Most recent Report, named "United States Pharmaceuticals Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a complete investigation of the business, which includes bits of knowledge available examination. The…
Global Intensive Care Beds Market Size, Emerging Trends, Growth, Opportunities a …
According to a new report published by CoherentMI The intensive care beds market size is expected to reach US$ 5.88 Bn by 2030, from US$ 3.45 billion in 2023, at a CAGR of 7.9% during the forecast period.
Most recent Report, named "Global Intensive Care Beds Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a complete investigation of the business, which includes bits of knowledge available examination.…
More Releases for Drugs
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database.
In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),…
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests.
On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.…
